Online Education (CME)

Best Practices in Prescribing Opioids and Controlled Substances
During the 2019 session, the Minnesota Legislature passed a law that requires individuals with licenses with the authority to prescribe controlled substances to obtain at least two hours of CME on best practices in prescribing opioids and controlled substances. This online, self-assessment activity includes content on best practices in prescribing opioids and controlled substances, as well as non-pharmacological and implantable device alternatives for treatment of pain and ongoing pain management. Read more here.

Cannabliss or Cannabust? Three Years of Medical Cannabis in Minnesota (members only)
Hear an update on the implementation and use of the state's medical cannabis program with data from the Minnesota Department of Health's Office of Medical Cannabis (OMC). Tom Arneson, MD, MMA member and OMC Research Director will discuss emerging medical cannabis research, share patient experiences and answer questions about the program.
‚Äč
COVID-19: A Focus on Employment, Benefits, and Financial Assistance for Physician Clinics
Listen as the MMA and legal experts from Dorsey & Whitney, LLP, discuss the possibility of changes to your business (e.g. staff layoffs, furloughs and associated employee benefits) in light of the COVID-19 pandemic as well as the potential financial protections for practices including the CARES Act (Coronavirus Aid, Relief, and Economic Security Act).

COVID-19: Federal Paycheck Protections Program and SBA Loans – an Update for Physician Practices
Legal experts from Dorsey & Whitney, LLP will discuss recent changes by Congress to the Paycheck Protection Program (PPP) and Small Business Administration (SBA) loans. Earlier this month, MMA hosted an online discussion introducing potential financial protections for practices including the CARES Act (Coronavirus Aid, Relief, and Economic Security Act). A recording of the April 7 program is also available.

The Dynamic Pharmaceutical Market
Prescription drugs are often prescribed by doctors to address specific patient healthcare needs. While sitting in the doctor’s waiting room, the patient often will think about “Will the doctor prescribe a medication and how much will it cost me?” The cost of prescription drugs is at the top of the public policy agenda and may affect the long-term viability of Medicare and Medicaid. Commercial health plans sponsored by employers and other private payers are concerned about the impact of drug prices on their total healthcare spending. At the same time, the news is full of stories that appear to be examples of price gouging on prescription drugs such as EpiPen, Insulin, HP Acthar, Daraprim, Colchrys, Glumetza, Zegerid, MS drugs, and others. Where are federal and state policy makers headed with drug pricing policy? What can you do for your patients with respect to getting needed medications at a reasonable cost?  

Easy Tools for Clinicians to Prevent Type 2 Diabetes
Twin Cities Medical Society has partnered with Minnesota Department of Health, Minneapolis Health Department and the Minnesota Medical Association to produce a webinar for providers with the latest research on Prediabetes, information on outcomes from the Diabetes Prevention Program studies and how the Diabetes Prevention Connection can help patients find a class, as well as new insurance coverage for screening and for the program cost.

Health System Panel Discussion
Hear from leaders at three Minnesota health care systems and one community health center, discuss how they are responding to address current barriers to accessing health care.

Implicit Bias Education Series
Implicit (unconscious) bias can develop over time with the accumulation of personal experience. Research suggests that implicit bias may contribute to health care disparities by shaping a clinician’s behavior and producing differences in medical treatment. This 2-part enduring activity will review factors that affect healthcare outcomes in Minnesotans and present tools to help our society move towards health equity.

Making Prescription Drugs Accessible and Affordable
This panel discussed the challenges that prescription drug costs have brought to patients and families in Minnesota and engaged the audience in a discussion of what policy changes are needed to ensure prescription drugs are both accessible and affordable.   

Medicare for All or None?
Medicare- for- all, in some version, will be an important part of political discourse for the foreseeable future. Hopefully one important consequence of that discourse will be a thoughtful assessment and restructuring of the existing Medicare program before any major expansion is attempted. But, can needed changes be accomplished in the present political environment?  These changes will occur only if stakeholders can be convinced to focus on their long-term interests in building a fair and stable Medicare program, as opposed to protecting themselves from short term losses. The early returns are not positive in this regard.

Opening Keynote Speaker – 2019 Annual Conference
Dr. Baechler kicked off the conference by providing an overview of the state of health in Minnesota as it relates to access to care challenges, where the opportunities for improvement lie, and how physicians can partner with the Minnesota Department of Health to preserve access to care for all Minnesotans.

Optimal Care of Memory-Impaired Persons for Providers
These webinars help providers understand when and how to apply practice tools in their day-to-day work with patients, including managing functional changes and behaviors that can complicate care and negatively impact outcomes. 

Pain, Opioids and Addiction Lecture Series
The Minnesota Medical Association (MMA), the Steve Rummler HOPE Network (SRHN), and the University of Minnesota Medical School collaborate to bring medical education on the topics of pain, opioids and addiction to medical students, residents, and practicing doctors.


Primer on Minnesota Access Problems & Vulnerabilities
This presentation shares trends over time in health insurance coverage in Minnesota as well as inequities in access to insurance by place, age, income, race and ethnicity. This is followed by a snapshot of challenges in accessing health care services, affordability of health insurance and health care.

What’s the Big Deal about Chlamydia
From the Minnesota Department of Health, discover the role of community partnerships in addressing Chlamydia while recognizing the best practices employed by clinics that serve adolescent and young adult patients in a youth-friendly way.